Clinical trial
Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select…
NCT00038181 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00038181 |
|---|---|
| Title | Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate Cancer |
| Official title | A Tolerance and Efficacy Trial of Preoperative Thalidomide Treatment Followed by Radical Retropubic Prostatectomy (RRP) in Select Patients With Locally Advanced Prostate Cancer |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Celgene Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Thalidomide |
| Enrollment | 18 |
| Start date | Oct 5, 2000 |
| Primary completion | Nov 29, 2005 |
| Completion | Nov 29, 2005 |
| First posted | May 30, 2002 |
| Last update posted | Nov 15, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: